HOME >> MEDICINE >> NEWS
Simulator can help stroke patients drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

Patients who received simulator training were also almost twice as likely as stroke patients without the training to pass an official driving test at the end of a five-week training period, according to Dr. Abiodun Akinwuntan, a Medical College of Georgia physical therapy instructor and the lead researcher on the study published in the Sept. 27 issue of Neurology.

"Traditionally, to help patients learn to drive again, therapists have relied on conventional methods like paper-and-pencil-based training and sometimes an on-road training method," Dr. Akinwuntan says. "I have never been a proponent of the on-road method because it can be unsafe. Healthy drivers find the roads dangerous enough."

In 2003, Dr. Akinwuntan and his colleagues at the Katholieke Universiteit in Leuven, Belgium, the Belgian Road Safety Institute in Brussels and University Hospital in Pellenberg, Belgium, studied 83 stroke patients in the rehabilitation unit of the hospital. Using a 20-mile computer-simulated course that Dr. Akinwuntan developed, patients practiced driving in a variety of traffic situations. Virtual rural and open roads, urban settings and highways each tested a different skill level.

"Rural, small roads have less traffic and test basic skills," he says. "The urban setting has more traffic and can test how well patients perform when their attention is divided among many distractions, and the highway setting gives an idea whether they understand what it means to overtake another car can they effectively react to other drivers and their maneuvers."

For training, patients drive in a specially equipped car on a course projected on a large screen in front of them. Mistakes are monitored both by computer and an observing evaluator. Patients using simulator training were more lik
'"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia
27-Sep-2005


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Women with migraines and visual symptoms may have higher stroke risk
3. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
4. Trial stops after stroke and mortality significantly reduced by blood
5. Future therapies for stroke may block cell death
6. Study outlines how stroke, head injury can increase risk of Alzheimers disease
7. QBI scientist looks at why stroke causes vision problems
8. Explaining a link between strokes and Alzheimers
9. Folic acid supplementation lowers stroke risk
10. TV ads may spur more stroke victims to get help sooner
11. Limiting stroke damage is focus of study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Simulator can help stroke patients drive again

(Date:5/20/2013)... CosmosID, a leading data mining solutions company for health ... results on analysis of labeling claims for the composition ... The Food and Drug Administration (FDA) and CosmosID conducted ... four of which have been reported at the American ... was to compare the identity of species and strains ...
(Date:5/20/2013)... Sporturf, an international manufacturer and builder of synthetic ... Midwest with the opening of the company’s third regional ... is under the leadership of President Craig Shonk, and ... , “This strategic move opens up a market ... Shonk. “Bringing an ISO manufacturer and a Midwest-based ASBA ...
(Date:5/20/2013)... Online education provides the convenience, flexibility and cost-saving ... According to the American Heart Association, 27% of ... to eLearning due to changing economic conditions. The ... budgets, but it is also proven to enhance ... higher retention of content is probable, given the ...
(Date:5/20/2013)... as a consequence of diabetic foot ulcer that does ... this situation are very limited. In his doctoral thesis ... Department of Medical Biochemistry and Biophysics at Ume University ... may completely change the lives of millions of patients. ... chronic wounds that largely impair the quality of life ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 BenefitMall, ... of employee benefit, payroll products and services and ... both are selected as finalists for the 2013 American ... Company of the Year category, and CompuPay is a ... finalist will ultimately be a Gold, Silver or Bronze ...
Breaking Medicine News(10 mins):Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3
(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)... 20, 2013  AbbVie (NYSE: ABBV ... 3 clinical study called SONAR (Study Of Diabetic ... the investigational compound atrasentan - when added to standard ... patients with stage 2 to 4 chronic kidney ... a large, multinational, double-blind, placebo-controlled clinical study that ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
Cached News: